Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Dexpramipexole

300 mg - Oral Tablets

DRUG

Dexpramipexole

600 mg Oral Tablets

DRUG

Dexpramipexole Placebo

Placebo - Oral Tablet

DRUG

Moxifloxacin

400 mg - Oral Tablet

Trial Locations (1)

Research Site, Overland Park